Skip to main content
Day.News — Local News. Real Community.
COLUMBUS DAY NEWS
Local News. Real Community.
health
1 min read

Federal Judge to Review $1.8 Billion Compensation Fund for Trump Administration

A federal judge has agreed to review a $1.8 billion fund established by the Trump administration to compensate individuals it says suffered wrongful treatment by the federal government. The fund's announcement sparked opposition across Republican and Democratic ranks.

06/13/2026 · Oregon edition

Advertisement

Advertisement

A federal judge has agreed to examine a $1.8 billion compensation fund created by the Trump administration to pay individuals the administration says the federal government wronged.

The fund announcement came earlier this month and prompted swift backlash from multiple quarters, including divisions within Republican leadership.

Details about the fund's structure, eligibility criteria, and administration remain limited in available reporting. The judge's review will examine the program's legal basis and operational framework.

Opponents have raised questions about the fund's establishment process and how it operates relative to existing federal compensation mechanisms. Supporters of the initiative have characterized it as addressing claims they believe the traditional legal system has inadequately resolved.

The fund's announcement exposed disagreements among Republicans about federal spending and the administration's priorities, signaling tension within the party as the administration pursues its policy agenda.

The judge's examination will determine whether the fund operates within legal constraints and whether it should continue in its current form or face modification. The outcome could affect how the administration compensates individuals going forward and may influence similar programs under consideration.

Related Topics

Editorial Transparency
AI-Generated · Written by National Desk

Article Ratings

Factual
0.0
Likeable
0.0
Bias
0.0
Objective
0.0

How do you feel about this story?

NA

National Desk

Trust 3.1104047 articles8,231,170 views75% fact accuracy
View Profile

Sign in to follow this author from their profile.

Discussion (0)

Join the Conversation

Join the conversation

Sign in to share your thoughts, reply to readers, and like comments.

Sign in to comment
Sort by:
0 comments

No comments yet. Be the first to comment!

Trending Now

Trending stories will appear here.

More from Oregon

No other local stories are available right now.

Events & Things to Do

Read section →

Upcoming events will appear here.

Advertisement

Advertisement

Keep Reading

Related Stories

More health stories from Oregon

health

Family Calls for Allergy Management Ratings After Child's Death

The family of Mia St Hilaire, a 12-year-old who died after an anaphylactic reaction, now advocates for improved allergy management ratings. Mia consumed a milkshake that triggered her tree nut allergy.

Read Story →
health

Discussion Addresses Mental Health, Suicide Trends in Black Community

NPR's Michel Martin hosted a panel discussion on mental health and suicide within the Black community. The conversation explored the subject through personal perspectives. Participants shared individual experiences.

Read Story →
health

FDA to Conclude Abortion Pill Safety Review by March

The Food and Drug Administration (FDA) will finalize its safety review of mifepristone in March. A Louisiana federal judge mandated this update as part of a legal challenge seeking to reverse a policy allowing mail delivery of the abortion medication.

Read Story →
health

GLP-1 Medications Show Potential in Addressing Addiction

New evidence suggests GLP-1 drugs, commonly used for diabetes and weight loss, may also reduce cravings for addictive substances. Scientists are conducting studies to determine if these medications can help individuals with substance use disorders. This research explores a potential new application for GLP-1s in public health.

Read Story →
health

Report Examines Impact of Trump Administration's Drug Pricing Initiatives

A recent report evaluated the Trump administration's claims regarding drug prices, including the effectiveness of TrumpRx discounts. Findings indicate a mixed impact on prescription drug costs for consumers. The administration has asserted that the U.S. now pays the world's lowest drug prices.

Read Story →
health

Cost of GLP-1 Medications Prompts Search for Alternatives

Many Americans face financial hurdles when trying to access GLP-1 medications. These cost barriers have prompted some patients to seek out alternative, unregulated versions. The situation highlights ongoing challenges in prescription drug affordability.

Read Story →
Scroll for more stories